Date
Title
Speaker
6/11/2018
Deciphering the metabolo-epigenetic activities of metformin
Elisabet Cuyàs
25/09/2018
A synthetic lethal CRISPR/Cas9 screen for castration resistant prostate cancer
Adrián Tébar
09/07/2018
Extraordinary Seminar: Identifying gene regulatory variants and GxE interactions for molecular and organismal traits
Roger Pique-Reig
04/07//2018
Extraordinary Seminar: Redox regulation of tumor microenvironment in triple negative breast cancer
Chiara Gorrini
3/07/2018
Therapeutic properties of E1a
Francisco José Cimas
19/06/2018
Adaptation to genomic instability, increase in oxidative metabolism?
Alvaro Lahiguera Belenguer
11/06/2018
Extraordinary Seminar: Computational Genomics in Biomedicine
David Torrents
5/06/2018
Role of CXCR2 pathway on taxane-acquired resistance and platinum sensitivity in metastatic prostate cancer cellular models
Vicençs Ruiz de Porras Fondevila
15/05/2018
Oncolytic Adenovirus expressing tumor neoepitopes as a vaccine
Martí Farrera
24/04/2018
Prognostic markers and therapeutic targets for metastatic Renal Cell Carcinoma
Mariona Bartroli Comellas
10/04/2018
Extraordinary Seminar: miR-424/503: the discovery of a new tumor suppressor gene
David Llobet Navas
21/03/2018
Extraordinary Seminar: Old challenges and new solutions unveiling intratumor heterogeneity
José Ignacio López Fernández de Villaverde
08/03/2018
Extraordinary Seminar: Breast tumor heterogeneity, resistance and metastasis
Mohamed Bentires-Alj
06/03/2018
PI3-kinase signalling regulates pericyte maturation during angiogenesis
Ana M. Figueiredo
20/02/2018
Serum biomarkers of lymphangioleiomyomatosis highlight novel therapeutic opportunities
Carmen Herranz
30/01/2018
Ongoing research projects in Malignant Pleural Mesothelioma. An update on the latest data
Elisabeth Aliagas
19/12/2017
Arming oncolytic adenovirus with FAP-targeting bispecific T-cell engager to improve antitumor efficacy
Jana de Sostoa
28/11/2017
CD44 involvement in tumor malignization induced by anti-angiogenic therapy in renal cell carcinoma
Jordi Sensarrich
26/09/2017
Tasting anti-cancer molecules in olive oil
Javier Menéndez
11/07/2017
Cancer modulators: a transversal ProCURE project
Luis Palomero
27/06/2017
PI3K signalling regulates cell rearrangements in angiogènesis
Ana Angulo
13/06/2017
Mechanisms of malignization after anti-VEGF therapies in renal cell carcinoma
Roser Pons
30/05/2017
A role for CXCR4 in hematogenous ovarian cancer dissemination
Agnès Figueras
16/05/2017
Human menstrual blood-derived mesenchymal stem cells as potencial cell carriers for oncolytic adenovirus
Rafael Moreno
02/05/2017
Epigenetic mechanisms and therapeutic opportunities metastatic castration resistent prostate cancer
Katia Ruggero
18/04/2017
PADI enzymes in skin and colorectal cancer
Neus Cantariño Iglesias
14/03/2017
Investigating the role of myeloid-derived HIF factors in retinal neovascularization
Pilar Villacampa Alcubierre
28/02/2017
Research lines in thoracic tumors
Ernest Nadal
07/02/2017
Stroma-mediated drug resistance in colorectal cancer
Samuel Gonçalves
24/01/2017
Translational study of lymphangioleiomyomatosis tissue origin, in vivo model and therapeutic strategies
Carmen Herranz